Welcome!Thank you for visiting! We look forward to seeing you.Welcome!Email is used by othersPlease enter user emailpassword reset link is sent to your email , the link will be expired in 30 mins
Hoffmann Jayer, Echezeaux Echezeaux Du Dessus Grand Cru, 2019
🏰 The 2019 vintage in Burgundy was generally considered excellent, producing wines with both richness and freshness. Hoffmann Jayer's Echezeaux du Dessus Grand Cru 2019 is expected to be a 【magnificent expression of this prestigious terroir】, offering a complex bouquet and a harmonious palate. While specific tasting notes for this exact wine and vintage are not widely available, Echezeaux Grand Cru wines typically showcase aromas of red and black fruits, floral notes like violet, and earthy undertones, evolving with age to reveal more savory and spicy characteristics. The palate is usually full-bodied with fine tannins and a long, elegant finish.
🍴 This exquisite red Burgundy pairs beautifully with classic French cuisine. Think roasted duck breast with cherry sauce, pan-seared foie gras, or a delicate beef tenderloin with truffle. For a more casual yet sophisticated pairing, consider mushroom risotto or aged Comté cheese. Cantonese cuisine could include roasted goose or pigeon, or even a delicate braised abalone dish to complement its elegance.
🥂 Perfect for a celebratory dinner, a special anniversary, or a serious tasting among connoisseurs. Its complexity and aging potential make it a wine to savor and contemplate.
BACKGROUND
Domaine Hoffmann-Jayer (formerly Jayer-Gilles) is an ten-hectare (25-acre) Burgundian wine estate. It is particularly known for Pinot Noir reds from Nuits-Saint-Georges and the Échézeaux Grand Cru. The cellar is situated in the village of Magny-lès-Villers in the Côte d'Or. The estate was founded in the 1950s by Robert Jayer, a cousin of Henri Jayer, and his wife Paulette. Their son Gilles began working there in 1991, taking over in 1998 and renaming it Jayer-Gilles. In 2017, Gilles sold the estate, but he passed away a year later at 57. The current owner is Swiss billionaire André Hoffmann, who has a background in the medical industry.